XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income (loss) $ 6,816,698 $ (737,892)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,754,871 7,015
Stock-based 401K company common match 0 0
Depreciation expense 18,958 7,231
Bargain purchase gain (11,729,882) 0
Changes in assets and liabilities:    
Prepaid expenses and other assets (181,679) 15,272
Accounts payable (620,212) 16,014
Accrued expenses (304,441) 288,022
Restructuring reserve (121,675) 0
Net cash used in operating activities (3,367,362) (404,338)
Cash flows from investing activities:    
Cash received in reverse merger transaction 29,106,512 0
Net cash used in investing activities 29,106,512 0
Cash flows from financing activities:    
Payments for capital lease obligation 0 (3,478)
Proceeds from issuance of common stock, net of issuance costs 750,000 1,055,999
Net cash provided by financing activities 750,000 1,052,521
Net increase in cash 26,489,150 648,183
Cash and cash equivalents at beginning of period 103,695 175,884
Cash and cash equivalents at end of period 26,592,845 824,067
Cash paid for:    
Interest 150 405
Supplemental cash flow information:    
Conversion of convertible notes and accrued interest into common stock 32,953 0
Consideration in connection with reverse merger transaction $ 15,793,638 $ 0